The University of Kansas Cancer Center was recently recognized as a “high-performing site” by the National Cancer Institute (NCI).
6-Feb-2018 8:05 PM EST Add to Favorites
Researchers at The University of Kansas Cancer Center have found that mitochondrial DNA may contain information that could help determine the likelihood of cancer metastasizing.
5-Feb-2018 2:40 PM EST Add to Favorites
Priyanka Sharma, M.D., a breast cancer medical oncologist at The University of Kansas Cancer Center, has been named vice chair of SWOG’s Breast Committee.
1-Feb-2018 11:05 AM EST Add to Favorites
Researchers at The University of Kansas Cancer Center are working to fill the knowledge gap between DNA damage and cancer, including developing approaches to manipulate the DNA damage response to treat and prevent disease. Their research on an...
24-Jan-2018 4:50 PM EST Add to Favorites
University of Kansas Announces Nearly $25 Million National Institutes of Health Grant to Accelerate Clinical and Translational Research
.The University of Kansas today announced and celebrated a five-year nearly $25 million grant from the National Institutes of Health that will fund Frontiers: University of Kansas Clinical and Translational Science Institute (KU CTSI). This grant...
9-Jan-2018 3:25 PM EST Add to Favorites
“Roy Jensen, through his leadership and collaboration, has brought NCI (National Cancer Institute) designation to our town
15-Dec-2017 12:05 PM EST Add to Favorites
Historic Partnership Grant Advances Immunotherapy Research of Mary Markiewicz, Ph.D., at the University of Kansas Cancer Center
.Mary Markiewicz, Ph.D., assistant professor at the University of Kansas Medical Center in the Department of Microbiology, Molecular Genetics and Immunology and a researcher with KU Cancer Center, will receive a grant, made possible by a unique...
31-Oct-2017 10:05 AM EDT Add to Favorites
CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer
CicloMed LLC announced that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was cleared by the U.S. Food and Drug Administration to begin human clinical trials. With this clearance, CicloMed...
11-Oct-2017 4:05 PM EDT Add to Favorites
see all news
Jennifer Klemp, PhD, MPH, director of cancer survivorship and an associate professor at The University of Kansas Cancer Center, is interviewed by Oncology Nursing News. In this interview, Klemp offers insights on some of the critical issues that...
31-Oct-2016 9:30 AM EDT
KU Cancer Center researcher is finding out why ovarian cancer is resistant to certain types of chemo to eventually identify a different drug target.
30-Jun-2015 5:05 PM EDT